Get the newest information from the Immunization Program right in your inbox!
Sign up
Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Complete the online reporting agreement form
Or fill out the
then email it to
vaxreporting@phila.gov
or fax to the contact above.
Complete in addition to the reporting agreement form to onboard more than 2 clinics.
Need help? Review the FAQ
There are no changes in vaccine recommendations and availability in Philadelphia. On Monday, January 5, 2026, the Centers for Disease Control and Prevention (CDC) updated the pediatric immunization schedule, changing several routine childhood vaccines from a routine recommended category to a shared-decision-making and/or high-risk category. Despite these...
RSV activity is elevated in many areas of the country, including Pennsylvania and Philadelphia. RSV (respiratory syncytial virus) immunization remains the most effective protection against RSV illness. A recent study showed that nirsevimab was 81% effective against RSV-associated hospitalization among infants younger than 6 months. Refer to these previous messages regarding availability and...
The health department has recently identified a varicella (chickenpox) outbreak in a school and is sharing clinical reminders on the diagnosis and management of varicella. Varicella is a highly contagious disease that can be serious for non-immune pregnant people, newborns, and those with weak immune...
The CDC released updated clinical guidance for the 2025-2026 COVID-19 vaccine. Previously, all unvaccinated children younger than 5 years were recommended to receive 2 doses of 2025-2026 Moderna vaccine as their primary series. Now, children aged 6-23 months who are unvaccinated are recommended to receive 2 doses...
On September 18-19, 2025, CDC's Advisory Committee on Immunization Practices (ACIP) voted to recommend: MMRV (combined MMR + varicella) vaccine should not be given to children under 4 years old. It is recommended to administer MMR and varicella vaccines separately. Clinical Background: MMRV Vaccine The MMRV vaccine is a...
VFC providers can now order Moderna, Pfizer, & Sanofi 2025-2026 COVID-19 products for their eligible patients.Make sure that your EHR/EMR is set-up to report this year’s COVID-19 products.These are the vaccines available this year: *Pfizer 6 mos - 4 years is no longer available.**This is a...
On February 14, 2025, the Food and Drug Administration (FDA) approved GSK’s MenABCWY vaccine, Penmenvy, for use in individuals aged 10 through 25 years. Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) is now available through the Vaccines for Children (VFC) program. The vaccine is...
On June 9, 2025, the Food and Drug Administration (FDA) licensed Merck’s Enflonsia (clesrovimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI).On June 26, 2025, the Advisory Committee on Immunization Practices(ACIP) voted to recommend clesrovimab for use in infants younger than...
Vaccines for Children (VFC) providers are now welcome to order nirsevimab (Beyfortus) as needed. Nirsevimab (Beyfortus), a monoclonal antibody immunization used to prevent RSV infection in infants and young children, can be administered from October 1, 2025 to March 31, 2026. Once we receive your nirsevimab orders,...
The following products are now available to order: Flulaval (VFC & VFAAR) Fluzone (VFC only) Flucelvax (VFC only) FluMist (VFC only) 2025-2026 Available Influenza Products Vaccines for Children (VFC) Product Manufacture/NDC Eligibility Dose / Presentation / Type CPT Code CVX Code Available FluLaval GSK, 19515-0904-52 6 mos – 18 years 0.5 mL / Single-dose syringe / inactivated, trivalent 90656 140 Yes Fluzone Sanofi, 49281-0425-50 6 mos – 18...
Effective immediately, all 2024-2025 COVID-19 products are no longer approved for use. Remove all 2024-2025 COVID-19 vaccines from storage units immediately, even if they are not expired. Discard any open vials of vaccine and adjust inventory using the Wasting Vaccine Guide. Return any unopened vials or syringes using the Vaccine Return Guide. Mark...
Can I order self- or caregiver-administered FluMist for patients in the upcoming influenza season? No, providers can not order self- or caregiver-administered FluMist for patients. Patients and/or caregivers must initiate the order themselves. FluMist can be ordered through an online pharmacy service, Asembia Specialty Pharmacy Network (ASPN)....
Beginning in September, the Philadelphia Immunization Program will be implementing a new ordering process for the Vaccines for Adults at Risk (VFAAR) program. All VFAAR orders should be submitted by the end of the day on the first Wednesday of each month. Orders will be reviewed...
Join us for an informative virtual session on respiratory viruses. This session is for both primary care physicians (PCPs) and other vaccine providers to learn more about: respiratory syncytial virus (RSV) influenza COVID-19 vaccine ordering, storage, and administration information Infectious disease expert Dr. Mayssa Abuali will give an overview of...
Nirsevimab (Beyfortus) ordering will begin in August for the 2025-2026 season. Nirsevimab (Beyfortus), a monoclonal antibody immunization used to prevent RSV infection in infants and young children, can be administered from October 1, 2025, to March 31, 2026. The CDC plans to continue releasing nirsevimab (Beyfortus) through...
In the face of rapidly shifting vaccine policies and public uncertainty, it’s more important than ever for healthcare providers to be equipped with tools that foster trust and clarity around vaccination. We’ve developed strategies to support your conversations with patients—strategies that address misconceptions, center patient concerns,...
On May 29, 2025, the CDC updated the routine Child and Adolescent Immunization Schedule. All moderately and severely immunocompromised children should receive the COVID-19 vaccine. All other children may receive the COVID-19 vaccine based on shared decision-making between the patient/parent and the pediatrician, combining the...
National Infant Immunization Week (NIIW) highlights the importance of protecting children two years and younger from vaccine-preventable diseases. Research consistently shows that healthcare professionals are the most trusted source of vaccine information for parents. Take this opportunity to speak about the importance of timely vaccination. Dr. Mayssa Abuali, Immunization Program Medical...